文献速递系统性红斑狼疮

白细胞介素4驱动的自身反应性B细胞失能逆转参与系统性红斑狼疮的发病机制

Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus.
PubMed 文献 · Ann Rheum Dis · 2023-08-11

本研究在分子和单细胞水平比较健康供者与系统性红斑狼疮(SLE)患者样本,发现SLE患者BND细胞减少和破坏,IL-4通过STAT6信号促进BCR再循环至细胞表面从而逆转B细胞失能,结论支持通过阻断IL-4信号治疗SLE并提供诊断和预后生物标志物。

要点

  • SLE患者中存在BND细胞减少和破坏。
  • IL-4是驱动上述病理变化的重要细胞因子。
  • IL-4通过STAT6信号促进BCR再循环至细胞表面以逆转B细胞失能。

核心结论

  • 研究证明IL-4在逆转B细胞失能中的重要意义,并建立了通过阻断IL-4信号治疗SLE的科学依据,同时提供诊断和预后生物标志物以识别最可能从此类治疗中获益的患者。

研究设计与样本

  • 研究对健康供者和SLE患者样本采用表型分析、大规模转录组分析和B细胞受体(BCR)库分析,在分子和单细胞水平进行研究。
  • 研究将人外周血分离的初始B细胞在体外用抗CD79b单克隆抗体处理以诱导失能,并用共聚焦显微镜追踪IgM内化、用流式细胞仪定量。

主要发现

  • 研究表征了SLE患者中BND细胞的减少和破坏,并证明IL-4是驱动此类病理变化的重要细胞因子。
  • 研究阐明IL-4通过STAT6信号促进BCR再循环至细胞表面从而逆转B细胞失能。

临床怎么用

  • 作者认为可通过阻断IL-4信号治疗SLE,并提供诊断和预后生物标志物以识别最可能从该治疗中获益的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Reactivation of anergic autoreactive B cells (BND cells) is a key aetiological process in systemic lupus erythematosus (SLE), yet the underlying mechanism remains largely elusive. This study aimed to investigate how BND cells participate in the pathogenesis of SLE and the underlying mechanism. METHODS: A combination of phenotypical, large-scale transcriptome and B cell receptor (BCR) repertoire profiling were employed at molecular and single cell level on samples from healthy donors and patients with SLE. Isolated naïve B cells from human periphery blood were treated with anti-CD79b mAb in vitro to induce anergy. IgM internalisation was tracked by confocal microscopy and was qualified by flow cytometer. RESULTS: We characterised the decrease and disruption of BND cells in SLE patients and demonstrated IL-4 as an important cytokine to drive such pathological changes. We then elucidated that IL-4 reversed B cell anergy by promoting BCR recycling to the cell surface via STAT6 signalling. CONCLUSIONS: We demonstrated the significance of IL-4 in reversing B cell anergy and established the scientific rationale to treat SLE via blocking IL-4 signalling, also providing diagnostic and prognostic biomarkers to identify patients who are most likely going to benefit from such treatments.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Liu Y, Zhang Z, Kang Z, et al. Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus. Ann Rheum Dis. 2023. PMID: 37567607. doi:10.1136/ard-2023-224453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。